Vaccines 2015, 3(1), 1-19; https://doi.org/10.3390/vaccines3010001
The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration
1
International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA
2
Chinese National Center for AIDS/STD Control and Prevention (NCAIDS), Beijing 102206, China
3
Futures Institute, Glastonbury, CT 06033, USA
4
Columbia University Global Centers, East Asia, Beijing 100080, China
5
PATH, Seattle, WA 98121, USA
6
Center for Disease Control and Prevention of Sichuan Province, Chengdu 610041, China
7
Joint United Nations Programme for HIV/AIDS (UNAIDS), Geneva CH-1211, Switzerland
*
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Received: 15 October 2014 / Accepted: 19 November 2014 / Published: 5 January 2015
(This article belongs to the Special Issue Feature Papers)
Abstract
China’s commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China’s response, even if not 100% efficacious or available to the full population. View Full-Text
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Harmon, T.; Guo, W.; Stover, J.; Wu, Z.; Kaufman, J.; Schneider, K.; Liu, L.; Feng, L.; Schwartländer, B. The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration. Vaccines 2015, 3, 1-19.
Related Articles
Article Metrics
Comments
[Return to top]
Vaccines
EISSN 2076-393X
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert